Clinical Trial: AK112 Combined With GAP Conversion Therapy for Locally Advanced Gallbladder Cancer

U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07767994) titled 'AK112 Combined With GAP Conversion Therapy for Locally Advanced Gallbladder Cancer' on Aug. 04.

Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of AK112 combined with the GAP regimen as conversion therapy for patients with locally advanced gallbladder cancer who are initially considered unsuitable for curative surgery.

The main questions this study aims to answer are:

1. Whether AK112 combined with the GAP regimen can increase the rate of successful R0 radical resection after conversion therapy.

2. Whether this treatment approach can achieve tumor response and disease control with acceptable ...